Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market
The market’s leading companies are concentrating on getting their products approved by regulatory bodies, which is anticipated to fuel market expansion over the projected period.
For instance, the drug-coated balloon catheter Prevail will be available in Europe starting in July 2021, according to Medtronic plc, a manufacturer of medical devices.
Additionally, in November 2020, the Regulatory, Surveillance and Control National Agency of Ecuador granted marketing approval to Shanghai MicroPort Medical (Group) Co., Ltd., which is an international medical device company, for its proprietary products, including FO (FOXTROT NC), Firehawk Rapamycin Target Eluting Coronary Stent System (Firehawk), Firefighter PTCA Balloon Catheter (Firefighter), and Firebird2 Coronary Rapamycin-Eluting CoCr Stent System (Firebird2).
The percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market is estimated to be valued at US$ 2.2 Billion in 2022 and is expected to exhibit a CAGR of 8 % over the forecast period (2022-2030).
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/5194
Impact
On December 31, 2019, Wuhan, China, received the first report of the coronavirus (COVID-19) epidemic. On March 11, 2020, the World Health Organization classified COVID-19 as a pandemic. Over 583,038,110 cases of coronavirus illness (COVID-19) were recorded through August 9, 2022, according to the World Health Organization’s Coronavirus (COVID-19) Weekly Epidemiological Update.
Additionally, the British Heart Foundation, which had been monitoring the COVID-19 situation in Europe, discovered that around 371,000 heart surgeries and treatments were carried out in 2020, a 22% decline from that in 2019, when 473,000 procedures were undertaken.
In order to improve their positions in the worldwide market, major market players are concentrating on implementing inorganic development methods including mergers, collaborations, partnerships, and acquisitions. In March 2021, the manufacturer of medical devices B. BIS, and the manufacturer of medical equipment Infraredx established a partnership for the testing of B. Braun SeQuent Please ReX. The businesses worked together to hasten the FDA IDE clinical trial for the drug-coated PTCA balloon catheter SeQuent Please ReX, which was designated a breakthrough device in 2019.
Key Takeaways
The PTCA balloon catheter market is predicted to expand at a CAGR of 8% over the forecast period due to a rise in product launches and approvals. For instance, the Scoreflex NC Scoring Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter from OrbusNeich was declared to have gained premarket (PMA) clearance from the US Food and Drug Administration in January 2022 by the medical device business Cardiovascular Systems, Inc.
The normal balloon catheter segment is estimated to have the largest market share across product types during the projected period as a result of growing R&D initiatives and new launches by market competitors. For instance, in April 2021, Cardiovascular Systems Inc., a manufacturer of medical devices, introduced the complete line of JADE over-the-wire (OTW) balloon catheters for percutaneous transluminal angioplasty in the United States. The company Cardiovascular Technologies Inc. creates systems to treat coronary and peripheral arterial disease.
S3V Vascular Technologies Pvt. Ltd., Cook Group, Nordson Corporation, Medtronic Plc., Scientific Corporation, Becton, Microport, Dickinson and Company, Shockwave Medical Inc., Abbott, Biomerics, Koninklijke Philips N.V., BIOTRONIK SE & Co. KG, ENDOCOR GmbH, Teleflex Incorporated, Cardinal Health, Surmodics, Inc., NIPRO, Terumo Boston Scientific Corporation, and others are significant market participants in the PTCA balloon catheter market.
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/5194
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Industry Impact
Chapter 2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Competition by Types, Applications, and Top Regions and Countries
2.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter (Volume and Value) by Type
2.3 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Analysis
Chapter 6 East Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Analysis
Chapter 7 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Analysis
Chapter 8 South Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Analysis
Chapter 9 Southeast Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Analysis
Chapter 10 Middle East Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Analysis
Chapter 11 Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Analysis
Chapter 12 Oceania Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Analysis
Chapter 13 South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Analysis
Chapter 14 Company Profiles and Key Figures in Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Business
Chapter 15 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Forecast (2022-2028)
Chapter 16 Conclusions
Research Methodology
We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/5194
About US
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us
Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com